Predictive and prognostic value of stromal tumor-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer

被引：0
|
作者：
Ochi, T.
Giampaolo, B.
Murai, M.
Nozaki, F.
Kobayashi, D.
Iwamoto, T.
Niikura, N.
Suzuki, K.
Yamauchi, H.
Hayashi, N.
机构：
[1] St Lukes Int Hosp, Tokyo, Japan
[2] Ist Sci San Raffaele, Milan, Italy
[3] Okayama Univ Hosp, Okayama, Japan
[4] Tokai Univ, Sch Med, Isehara, Kanagawa, Japan
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P2-08-31
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-08-31
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Stromal ColXα1 and Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer Depending on Estrogen Receptor Status
    Ouseph, Madhu
    Brodsky, Alexander
    Xiong, Jinjun
    Yang, Dongfang
    Resnick, Murray B.
    Wang, Yihong
    LABORATORY INVESTIGATION, 2016, 96 : 63A - 63A
  • [22] Tumor-infiltrating lymphocytes: a prognostic biomarker in neoadjuvant-treated HR positive/HER2 negative breast cancer
    Liu, Yilong
    Zhu, Changyu
    Tong, Rongsheng
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A95 - A96
  • [23] Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
    Liefaard, M. C.
    van der Voort, A.
    van Seijen, M.
    Thijssen, B.
    Sanders, J.
    Vonk, S.
    Mittempergher, L.
    Bhaskaran, R.
    de Munck, L.
    van Leeuwen-Stok, A. E.
    Salgado, R.
    Horlings, H. M.
    Lips, E. H.
    Sonke, G. S.
    NPJ BREAST CANCER, 2024, 10 (01)
  • [24] Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies
    Hida, Akira I.
    Sagara, Yasuaki
    Yotsumoto, Daisuke
    Kanemitsu, Shuichi
    Kawano, Junko
    Baba, Shinichi
    Rai, Yoshiaki
    Oshiro, Yumi
    Aogi, Kenjiro
    Sagara, Yoshiaki
    Ohi, Yasuyo
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) : 1 - 9
  • [25] Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies
    Akira I. Hida
    Yasuaki Sagara
    Daisuke Yotsumoto
    Shuichi Kanemitsu
    Junko Kawano
    Shinichi Baba
    Yoshiaki Rai
    Yumi Oshiro
    Kenjiro Aogi
    Yoshiaki Sagara
    Yasuyo Ohi
    Breast Cancer Research and Treatment, 2016, 158 : 1 - 9
  • [26] Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2-Negative Postmenopausal Breast Cancer Patients
    Pousette, Jenny
    Johansson, Annelie
    Jonsson, Carolin
    Fornander, Tommy
    Lindstrom, Linda S.
    Olsson, Hans
    Perez-Tenorio, Gizeh
    CANCERS, 2022, 14 (19)
  • [27] Predictive and prognostic value of tumor-infiltrating lymphocytes in breast cancer treated with neoadjuvant chemotherapy.
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Hiraiwa, Kunihiko
    Nakamura, Tetsuya
    Saito, Junichi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [28] Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges
    Schlam, I.
    Loi, S.
    Salgado, R.
    Swain, S. M.
    ESMO OPEN, 2025, 10 (02)
  • [29] Investigating the role of tumor-infiltrating lymphocytes in advanced HER2-positive breast cancer
    Luen, Stephen J.
    Loi, Sherene
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (01)
  • [30] Clinical Significance of Stromal Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer
    Goel, Kanika
    Carter, Gloria
    Clark, Beth
    Fine, Jeffrey
    Yu, Jing
    Harinath, Lakshmi
    Villatoro, Tatiana
    Bhargava, Rohit
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 117 - 119
12345